Search

Live Cell Encapsulation Market

Live Cell Encapsulation Market Size By Method (Nanoencapsulation, Microencapsulation, and Macroencapsulation), By Polymer Type (Alginate, Silica, Chitosan, Cellulose Sulfate, and Others), By Application (Drug Delivery, Cell Transplantation, Regenerative Medicine, and Others), Regions, Global Industry Analysis, Share, Growth, and Trends. Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13387
  • Published Date: Mar, 2023
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global live cell encapsulation market is expected to reach USD 339.2 million by 2032, at a CAGR of 3.1% during the forecast period 2023 to 2032. Asia Pacific is expected to grow the fastest during the forecast period.

Market Overview:

In live cell encapsulation, living cells are enclosed in a protective material. This technology enables the safe and controlled delivery of cell-based therapies and research. A live cell-encapsulated drug or treatment system provides several advantages, including easy administration, the ability to control the release rate of a drug over time, and the ability to provide desired, preprogramed drug release, which is expected to boost industry growth over the forecasted period. Live cells are encapsulated and released within the body at a controlled temperature to avoid destruction by the body's immune system. In addition, in-vivo studies can be conducted on these cells without harming the host. To meet the increasing demand for targeted therapies, live cell encapsulation technology has become increasingly important. The growing investment from public-private partnerships has boosted the market. However, the need for raw material availability may affect its growth. Moreover, high manufacturing costs for encapsulated live cell capsules are the leading market restraints. Furthermore, encapsulated drugs are expected to be readily available to treat CNS disorders since they can easily cross the blood-brain barrier. Type 1 diabetes is another condition that microencapsulation can treat as well. Encapsulation protects pharmaceuticals from the biological environment and makes them readily absorbable in this state.

Live Cell Encapsulation Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In May 2022, A global strategic partnership between Sernova Corp. and Evotec SE was announced to create the most excellent cell therapy product for people with insulin-dependent diabetes. To develop an implantable iPSC-based (induced pluripotent stem cells) beta cell replacement therapy that will offer patients with insulin-dependent diabetes an infinite source of insulin-producing cells, the two companies will collaborate and draw on their respective technologies and scientific expertise.

Market Dynamics:

Drivers

The rise in product development- Market trends in cell technology will be driven by substantial public and private sector funding for product development and research activities to improve clinical trial efficiency. Furthermore, as people become more aware of the critical role of encapsulated cells in chronic diseases, the live cell encapsulation industry will grow.

Restraints:

High cost- A key impediment to market growth will be the high manufacturing costs of live cell encapsulation technology. Additionally, live cell encapsulation will need more raw materials, limiting the market. Furthermore, the increased use of alternative therapies will further restrict market growth.

Opportunities:

Rising usage of cell encapsulation procedure- Healthcare practitioners and medical specialists are increasingly using cell encapsulation procedures, one of the few factors contributing to the growth of the live cell encapsulation market. In addition to the increasing prevalence of target disorders, innovative drug delivery systems to treat chronic illnesses and technological advances contribute to industry growth.

Challenges:

Limited availability- As alternative treatment methods become more widely adopted, the live cell encapsulation market is expected to be squeezed by limited access to quality raw materials.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global live cell encapsulation market, with a 37.98% market revenue share in 2022.

North America dominates the live cell encapsulation market with a 37.98% market revenue share in 2022. Due to the growing private-sector funding, favourable rules, and government aid. The region primarily focuses on drug discovery research, pushing industry expansion. The presence of innovators and critical operational players has resulted in greater product penetration in the region. For example, ViaCyte, Inc. announced the start of phase 2 clinical investigation of encapsulated cell therapy to treat type 1 diabetic patients in February 2021. Such activities are expected to boost the company's industry position in North America.

Asia Pacific is expected to witness the fastest growth during the forecast period. The rapid increase can be ascribed to advancements in emerging economies such as India and China's biotechnology and pharmaceutical industries. This region's profitable expansion can also be attributed to continuous government backing for emerging countries' pharmaceutical sectors. Furthermore, current research in cancer and infectious diseases, such as COVID-19, will likely fuel significant growth in the region's live-cell encapsulation market.

North America Region Live Cell Encapsulation Market Share in 2022 - 37.98%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Method Analysis:

The method segment is divided into nanoencapsulation, microencapsulation, and macroencapsulation. The microencapsulation segment dominated the market, with a market share of around 37.56% in 2022. The microencapsulation technique encapsulates a bioactive material in a particle size of 1-1000 m for sustained and controlled administration and protection of the encapsulated bioactive ingredient from the surrounding environment. Microencapsulation offers several therapeutic uses in treating diseases such as tuberculosis, rheumatoid arthritis, diabetes, cancer, and respiratory tract infection. Islets of Langerhans, for example, are microencapsulated and implanted in the body for long-term therapy of diabetes or other diseases that necessitate organ transplantation.

Polymer Type Analysis:

The polymer type segment is divided into alginate, silica, chitosan, cellulose sulfate, and others. The alginate segment dominated the market, with a market share of around 40.23% in 2022. Alginate is one of the most commonly used polysaccharides and polymers for medicinal agent encapsulation. Alginate is derived from a brown seaweed species and manufactured by two bacteria species, Pseudomonas and Azotobacter. The alginate segment's rise is primarily due to characteristics such as alginate's high permeability, homogenous cellular architectures, and high mechanical stability.

Application Analysis:

The application segment is divided into drug delivery, cell transplantation, regenerative medicine, and others. The drug delivery segment dominated the market, with a market share of around 38.67% in 2022. Cell encapsulation provides effective drug delivery capsules, tablets, and parenteral dosage forms. Because of its procedural advantages, the rising usage of cell encapsulation for drug delivery is driving the expansion of this industry (such as reduced toxicity, improved efficacy, and improved patient convenience and compliance). Cell encapsulation is employed in the production of effective drug delivery systems. The benefits of this kind of drug delivery are its efficacy, tolerability, and patient compliance. For example, according to a study published in October 2021 titled "Encapsulation methods of active molecules for drug delivery," live cell encapsulation provides a preferential accumulation of active molecules at particular tissue cells or places while improving medication permeability and solubility, adverse effects, bioavailability, and therapeutic effectiveness.

List of Key Market Players:
  • AUSTRIANOVA
  • Living Cell Technologies Ltd.
  • Merck KGaA
  • Diatranz Otsuka Ltd.
  • Sphere Fluidics Ltd.
  • ViaCyte, Inc.
  • Blacktrace Holdings Ltd. (Dolomite Microfluidics)
  • BIO INX
  • Isogen
  • Sigilon Therapeutics, Inc.

Report Description: 

Attribute Description
Market Size Revenue (USD Million)
Market size value in 2022 USD 250 million
Market size value in 2032 USD 339.2 million
CAGR (2023 to 2032) 3.1%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Regional Segments North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Segments Method, Polymer Type, Application

Frequesntly Asked Questions

As per The Brainy Insights, the size of the live cell encapsulation market was valued at USD 250.0 million in 2022 to USD 339.2 million by 2032.

The global live cell encapsulation market is growing at a CAGR of 3.1% during the forecast period 2023-2032.

North America emerged as the largest live cell encapsulation market.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Method
          4.3.2. Market Attractiveness Analysis by Polymer Type
          4.3.3. Market Attractiveness Analysis by Application
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rise in product development
    5.3. Restraints
          5.3.1. High cost
    5.4. Opportunities
          5.4.1. Rising usage of cell encapsulation procedure
    5.5. Challenges
          5.5.1. Limited availability

6. Global Live Cell Encapsulation Market Analysis and Forecast, By Method
    6.1. Segment Overview
    6.2. Nanoencapsulation
    6.3. Microencapsulation
    6.4. Macroencapsulation

7. Global Live Cell Encapsulation Market Analysis and Forecast, By Polymer Type
    7.1. Segment Overview
    7.2. Alginate
    7.3. Silica
    7.4. Chitosan
    7.5. Cellulose Sulfate
    7.6. Others

8. Global Live Cell Encapsulation Market Analysis and Forecast, By Application
    8.1. Segment Overview
    8.2. Drug Delivery
    8.3. Cell Transplantation
    8.4. Regenerative Medicine
    8.5. Others

9. Global Live Cell Encapsulation Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Live Cell Encapsulation Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Live Cell Encapsulation Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. AUSTRIANOVA
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Living Cell Technologies Ltd.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Merck KGaA
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Diatranz Otsuka Ltd.
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Sphere Fluidics Ltd.
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. ViaCyte, Inc.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Blacktrace Holdings Ltd. (Dolomite Microfluidics)
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. BIO INX
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Isogen
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Sigilon Therapeutics, Inc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

2. Global Nanoencapsulation, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

3. Global Microencapsulation, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

4. Global Macroencapsulation, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

5. Global Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

6. Global Alginate, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million)

7. Global Silica, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million)

8. Global Chitosan, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million)

9. Global Cellulose Sulfate, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million)

10. Global Others, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million)

11. Global Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

12. Global Drug Delivery, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

13. Global Cell Transplantation, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

14. Global Regenerative Medicine, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

15. Global Others, Live Cell Encapsulation Market, By Region, 2019-2032 (USD Million) 

16. North America Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

17. North America Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

18. North America Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

19. U.S. Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

20. U.S. Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

21. U.S. Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

22. Canada Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

23. Canada Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

24. Canada Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

25. Mexico Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

26. Mexico Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

27. Mexico Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

28. Europe Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

29. Europe Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

30. Europe Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

31. Germany Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

32. Germany Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

33. Germany Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

34. France Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

35. France Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

36. France Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

37. U.K. Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

38. U.K. Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

39. U.K. Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

40. Italy Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

41. Italy Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

42. Italy Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

43. Spain Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

44. Spain Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

45. Spain Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

46. Asia Pacific Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

47. Asia Pacific Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

48. Asia Pacific Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

49. Japan Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

50. Japan Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

51. Japan Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

52. China Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

53. China Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

54. China Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

55. India Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

56. India Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

57. India Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

58. South America Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

59. South America Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

60. South America Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

61. Brazil Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

62. Brazil Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

63. Brazil Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

64. Middle East and Africa Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

65. Middle East and Africa Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

66. Middle East and Africa Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

67. UAE Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

68. UAE Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

69. UAE Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

70. South Africa Live Cell Encapsulation Market, By Method, 2019-2032 (USD Million)

71. South Africa Live Cell Encapsulation Market, By Polymer Type, 2019-2032 (USD Million)

72. South Africa Live Cell Encapsulation Market, By Application, 2019-2032 (USD Million)

List of Figures 

1. Global Live Cell Encapsulation Market Segmentation

2. Global Live Cell Encapsulation Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Live Cell Encapsulation Market Attractiveness Analysis by Method

9. Global Live Cell Encapsulation Market Attractiveness Analysis by Polymer Type

10. Global Live Cell Encapsulation Market Attractiveness Analysis by Application

11. Global Live Cell Encapsulation Market Attractiveness Analysis by Region

12. Global Live Cell Encapsulation Market: Dynamics

13. Global Live Cell Encapsulation Market Share by Method (2023 & 2032)

14. Global Live Cell Encapsulation Market Share by Polymer Type (2023 & 2032)

15. Global Live Cell Encapsulation Market Share by Application (2023 & 2032)

16. Global Live Cell Encapsulation Market Share by Regions (2023 & 2032)

17. Global Live Cell Encapsulation Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global Live Cell Encapsulation market based on the below-mentioned segments:

Global Live Cell Encapsulation Market By Method:

  • Nanoencapsulation
  • Microencapsulation
  • Macroencapsulation

Global Live Cell Encapsulation Market By Polymer Type:

  • Alginate
  • Silica
  • Chitosan
  • Cellulose Sulfate
  • Others

Global Live Cell Encapsulation Market By Application:

  • Drug Delivery
  • Cell Transplantation
  • Regenerative Medicine
  • Others

Global Live Cell Encapsulation Market By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date